From Breakthroughs Blog: Ebola

 
PATH/Satvir Malhotra
Research Roundup: Single-dose Ebola drug, mosquito birth control, and new TB treatment

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Mike Wang
Research Roundup: New treatment for sleeping sickness, innovations to combat AMR, and Merck Ebola vaccine update

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Satvir Malhotra
Research Roundup: Chikungunya vaccine trial, Ebola vaccine technology, and Zika biomarkers could lead to prenatal diagnostic

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Satvir Malhotra
Research Roundup: Effective experimental Ebola treatments, once-monthly injection to suppress HIV, and malaria-detecting dogs

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Dan Chang
Research Roundup: Tech to stop a pandemic, DNA vaccine against Ebola, and a unique way to attack malaria

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Eric Becker
Research Roundup: Neutralizing Ebola, a prototype to fight the next pandemic, and Zika vaccine trial moves forward

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Georgina Goodwin
Research Roundup: Ebola vaccinations in North Kivu, the role of biobanks in research, and a new Zika vaccine candidate

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Patrick McKern
Research Roundup: R&D investment in Africa, genetically modified rice to help prevent HIV, and antibodies for three Ebola viruses

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Patrick McKern
Research Roundup: Dangerous outbreaks, commercializing a low-cost biologics platform, and success against an infection that blinds

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Eric Becker
Research Roundup: An experimental Ebola vaccine, new viruses discovered, and Australian experiment wipes out disease-carrying mosquitoes

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Lynn Heinisch
Research Roundup: Improved Ebola & malaria diagnostics and gene therapy to foster HIV immunity

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Celebrating ten years of GHTC & a decade of progress in global health innovation

As we close out our 10th anniversary year, we wanted to take a moment to reflect on our shared progress and celebrate the headlines and moments that shaped global health R&D over the past decade. Check out some of the highlights...

Read More
Umit Kartoglu
Research Roundup: Forest loss and Ebola, antibody-caused dengue complications, and a mosquito-monitoring platform

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Rocky Prajapati
Research Roundup: The immunization edition

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Andrew Berends
Research Roundup: Zika vaccine dead ends, an Ebola data-sharing platform, and a low-cost newborn asphyxia treatment

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Evelyn Hockstein
Research Roundup: Plants as vaccines, the African CDC, and herd immunity in Zika

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Satvir Malhotra
Research Roundup: Vaccines as a tool to cure and protect, and what went right in the DRC Ebola outbreak

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: Underestimating Zika & Chagas and hopes for the Ebola vaccine in the DRC

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Rocky Prajapati
Research Roundup: Potential malaria and Ebola vaccines and the polio vaccine shortage

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Eric Becker
Research Roundup: The rise of drug-resistant TB, ecosystems and pandemics, and a UN-made global mosquito tracker

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
National Institute of Allergy and Infectious Diseases
Research Roundup: Treating drug-resistant infections, Ebola virus mutations, and Zika vaccine clinical trials

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Army Medicine
Research Roundup: Ebola treatment, black widow virus, and Zika syndrome

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Evelyn Hockstein/PATH
Research Roundup: Trojan horse antibody against Ebola, the breakthrough that led to Hepatitis C cures, and Zika infection in monkeys

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Robin Biellik
Research Roundup: Diagnostics to combat antimicrobial resistance, vaccines for pandemic threats, and more

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
David Jacobs
Research Roundup: Antibiotics, Zika vaccine R&D, and Ebola and malaria co-infection

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
James Gathany
Research Roundup: Viral hepatitis, treatment for persistent Ebola, E. coli–based vaccines

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Sanofi Pasteur / Patrick Boulen
Yellow fever: Status of research, development, and access to countermeasures against an emerging epidemic

GHTC breaks down the status of R&D for vaccines, drugs, and diagnostics against yellow fever.

GHTC
Read More
PATH/Jan Jacobs
Research Roundup: a rapid diagnostic for Ebola and fighting mosquito-borne diseases with soap and coconuts

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Ebola funding boost hides ongoing decline in neglected disease R&D

In this guest post, Anna Doubell, an analyst at Policy Cures, writes about the findings of this year’s G-FINDER report on neglected disease research and development (R&D). Supporting data from the report was released this week and is now available online through the G-FINDER public search tool.

Policy Cures
Read More
Research Roundup: an Ebola vaccine, stillbirths, and antimicrobial R&D

Gavi, the Vaccine Alliance, signed an advanced purchase commitment, pledging to spend US$5 million on an Ebola vaccine currently under development by pharmaceutical company Merck & Co.

GHTC
Read More
Research Roundup: Ebola treatments, drug-resistant gonorrhea, and zoonotic tuberculosis

A recent clinical trial found that convalescent plasma therapy, a treatment in which the blood plasma is taken from survivors of a disease and used to treat current patients, did not prove to be effective against Ebola.

GHTC
Read More